Portefeuille d'ETF ESGV (CBOE) - Page 63 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

NABL N-able Inc/US 38.22280000000 K 8 687.00000000000 0.00032712395%

RNA Atrium Therapeutics Inc 37.18770000000 K 2 521.20000000000 0.00031826521%

ALIT Alight Inc 32.28939000000 K 36.70500000000 K 0.00027634377%

SABR Sabre Corp 31.55792000000 K 26.74400000000 K 0.00027008360%

EVH Evolent Health Inc 19.77625000000 K 6 085.00000000000 0.00016925199%

RPD Rapid7 Inc 18.69110000000 K 3 005.00000000000 0.00015996490%

OmniAb Inc 0.01000000000 1 051.00000000000 0.00000000009%

Nouvelles

Large Caps - Big Opportunity

Q1 2026 Dividend Check-In: Highest Quarterly Hike Percentage Since 2019

Small Cap Momentum Moderates

Sentiment Sours On AI Substitution

Small-Cap Stocks Are Stirring On Policy Shifts, Earnings Edge

Equity Market Outlook Q1 2026: Macro Tailwinds Galore, But Mind The Risks

ESGV ETF: Still Ahead Of The Benchmark, But Some Peers Are More Compelling (BATS:ESGV)

Benchmark Blind Spots: Detecting Hidden Risks In Disruptive Markets

Capital Markets Outlook Q4 2025: Kicking The Can Down The Tightrope

Equity Outlook: From Caution To Complacency?

The U.S. Exceptionalism Mall Map: 'You Are Here'

ESGV: Strong Performance, Low Cost, But Not A Differentiated ESG Play (BATS:ESGV)